Cliff Asness's CMPX Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 155,218 shares of Compass Therapeutics, Inc. (CMPX) worth $833,521, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Cliff Asness has maintained this position in CMPX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2025, adding 96,070 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Compass Therapeutics (CMPX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Compass Therapeutics (CMPX) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +96,070 | Add 162.42% | 155,218 | $5.37 |
| Q3 2025 | +10,697 | Add 22.08% | 59,148 | $3.50 |
| Q2 2025 | +48,451 | New Buy | 48,451 | $2.60 |
Cliff Asness's Compass Therapeutics Investment FAQs
Cliff Asness first purchased Compass Therapeutics, Inc. (CMPX) in Q2 2025, acquiring 48,451 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Compass Therapeutics, Inc. (CMPX) for 3 quarters since Q2 2025.
Cliff Asness's largest addition to Compass Therapeutics, Inc. (CMPX) was in Q4 2025, adding 155,218 shares worth $833,521.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 155,218 shares of Compass Therapeutics, Inc. (CMPX), valued at approximately $833,521.
As of the Q4 2025 filing, Compass Therapeutics, Inc. (CMPX) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Compass Therapeutics, Inc. (CMPX) was 155,218 shares, as reported at the end of Q4 2025.